Home Applications 072028 Application 072028
Type ANDA
Sponsor ASTRAZENECA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FENTANYL CITRATE AND DROPERIDOL DROPERIDOL; FENTANYL CITRATE INJECTABLE;INJECTION 2.5MG/ML;EQ 0.05MG BASE/ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A072028-001 FENTANYL CITRATE AND DROPERIDOL DROPERIDOL; FENTANYL CITRATE 2.5MG/ML;EQ 0.05MG BASE/ML INJECTABLE / INJECTION 1989-04-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A072028-001 FENTANYL CITRATE AND DROPERIDOL 2.5MG/ML;EQ 0.05MG BASE/ML INJECTABLE / INJECTION 1989-04-13 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A072028-001 FENTANYL CITRATE AND DROPERIDOL 2.5MG/ML;EQ 0.05MG BASE/ML INJECTABLE / INJECTION 1989-04-13 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A072028-001 FENTANYL CITRATE AND DROPERIDOL 2.5MG/ML;EQ 0.05MG BASE/ML INJECTABLE / INJECTION 1989-04-13 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A072028-001 FENTANYL CITRATE AND DROPERIDOL 2.5MG/ML;EQ 0.05MG BASE/ML INJECTABLE / INJECTION 1989-04-13 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.